D4S234E, a novel p53-responsive gene, induces apoptosis in response to DNA damage

Experimental Cell Research

Volumn 316, Issue 17, 2010, Pages 2849-2858

  Kudoh, Takuya ^a   Kimura, Junko ^a   Lu, Zheng Guang ^a   Miki, Yoshio ^a   Yoshida, Kiyotsugu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; D4S234E; DNA damage; P53

Indexed keywords

PROTEIN P53; CARRIER PROTEIN; NERVE PROTEIN; NSG1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; D4S234E GENE; DNA DAMAGE; ENDOPLASMIC RETICULUM; GENE; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA INTERFERENCE; CELL LINE; DNA REPAIR; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; HUMAN GENOME; METABOLISM; PHYSIOLOGY; PROMOTER REGION; TRANSCRIPTION INITIATION;

APOPTOSIS; CARRIER PROTEINS; CELL LINE; DNA DAMAGE; DNA REPAIR; ENDOPLASMIC RETICULUM; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOME, HUMAN; HUMANS; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77956881990     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.06.025     Document Type: Article

References (46)

1. Birch J.M., Blair V., Kelsey A.M., Evans D.G., Harris M., Tricker K.J., Varley J.M. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene 1998, 17:1061-1068.
2. Olivier M., Goldgar D.E., Sodha N., Ohgaki H., Kleihues P., Hainaut P., Eeles R.A. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res. 2003, 63:6643-6650.
3. Vogelstein B., Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 2004, 10:789-799.
4. Finlay C.A., Hinds P.W., Levine A.J. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989, 57:1083-1093.
5. Sherr C.J. Principles of tumor suppression. Cell 2004, 116:235-246.
6. Zilfou J.T., Lowe S.W. Tumor suppressive functions of p53. Cold Spring Harbor Perspect. Biol. 2009, 1:a001883.
7. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
8. Lane D.P., Lain S. Therapeutic exploitation of the p53 pathway. Trends Mol. Med. 2002, 8:S38-42.
9. Yoshida K., Miki Y. The cell death machinery governed by the p53 tumor suppressor in response to DNA damage. Cancer Sci. 2010, 101:831-835.
10. Yoshida K. Nuclear trafficking of pro-apoptotic kinases in response to DNA damage. Trends Mol. Med. 2008, 14:305-313.
11. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816.
12. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993, 366:701-704.
13. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
14. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S., Kinzler K.W., Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1997, 1:3-11.
15. Lindsten T., Ross A.J., King A., Zong W.X., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., Chen Y., Wei M., Eng V.M., Adelman D.M., Simon M.C., Ma A., Golden J.A., Evan G., Korsmeyer S.J., MacGregor G.R., Thompson C.B. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 2000, 6:1389-1399.
16. Zhou B.B., Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408:433-439.
17. Sun Y. p53 and its downstream proteins as molecular targets of cancer. Mol. Carcinog. 2006, 45:409-415.
18. Ho J., Benchimol S. Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ. 2003, 10:404-408.
19. Speidel D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol. 2010, 20:14-24.
20. Nakamura Y. Isolation of p53-target genes and their functional analysis. Cancer Sci. 2004, 95:7-11.
21. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
22. Taira N., Nihira K., Yamaguchi T., Miki Y., Yoshida K. DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol. Cell 2007, 25:725-738.
23. Burlacu A. Regulation of apoptosis by Bcl-2 family proteins. J. Cell. Mol. Med. 2003, 7:249-257.
24. Sax J.K., Fei P., Murphy M.E., Bernhard E., Korsmeyer S.J., El-Deiry W.S. BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol. 2002, 4:842-849.
25. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288:1053-1058.
26. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 2001, 7:683-694.
27. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2002, 2:594-604.
28. Carlock L., Vo T., Lorincz M., Walker P.D., Bessert D., Wisniewski D., Dunbar J.C. Variable subcellular localization of a neuron-specific protein during NTera 2 differentiation into post-mitotic human neurons. Brain Res. Mol. Brain Res. 1996, 42:202-212.
29. Steiner P., Sarria J.C., Glauser L., Magnin S., Catsicas S., Hirling H. Modulation of receptor cycling by neuron-enriched endosomal protein of 21 kD. J. Cell Biol. 2002, 157:1197-1209.
30. Debaigt C., Hirling H., Steiner P., Vincent J.P., Mazella J. Crucial role of neuron-enriched endosomal protein of 21kDa in sorting between degradation and recycling of internalized G-protein-coupled receptors. J. Biol. Chem. 2004, 279:35687-35691.
31. Jayakar S.S., Dikshit M. AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs. Int. J. Neurosci. 2004, 114:695-734.
32. Steiner P., Alberi S., Kulangara K., Yersin A., Sarria J.C., Regulier E., Kasas S., Dietler G., Muller D., Catsicas S., Hirling H. Interactions between NEEP21, GRIP1 and GluR2 regulate sorting and recycling of the glutamate receptor subunit GluR2. EMBO J. 2005, 24:2873-2884.
33. Utvik J.K., Haglerod C., Mylonakou M.N., Holen T., Kropf M., Hirling H., Skare O., Laake P., Ottersen O.P., Haug F.M., Davanger S. Neuronal enriched endosomal protein of 21kDa colocalizes with glutamate receptor subunit GLUR2/3 at the postsynaptic membrane. Neuroscience 2009, 158:96-104.
34. Alberi S., Boda B., Steiner P., Nikonenko I., Hirling H., Muller D. The endosomal protein NEEP21 regulates AMPA receptor-mediated synaptic transmission and plasticity in the hippocampus. Mol. Cell. Neurosci. 2005, 29:313-319.
35. Kulangara K., Kropf M., Glauser L., Magnin S., Alberi S., Yersin A., Hirling H. Phosphorylation of glutamate receptor interacting protein 1 regulates surface expression of glutamate receptors. J. Biol. Chem. 2007, 282:2395-2404.
36. Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat. Cell Biol. 2005, 7:278-285.
37. Yoshida K., Wang H.G., Miki Y., Kufe D. Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9. EMBO J. 2003, 22:1431-1441.
38. Yoshida K., Liu H., Miki Y. Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J. Biol. Chem. 2006, 281:5734-5740.
39. Nguyen S.T., Hasegawa S., Tsuda H., Tomioka H., Ushijima M., Noda M., Omura K., Miki Y. Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma. Cancer Sci. 2007, 98:740-746.
40. Marinescu V.D., Kohane I.S., Riva A. MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinform. 2005, 6:79.
41. Teasdale R.D., Jackson M.R. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus. Annu. Rev. Cell Dev. Biol. 1996, 12:27-54.
42. Oyadomari S., Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004, 11:381-389.
43. Breckenridge D.G., Germain M., Mathai J.P., Nguyen M., Shore G.C. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 2003, 22:8608-8618.
44. Araki E., Oyadomari S., Mori M. Endoplasmic reticulum stress and diabetes mellitus. Intern. Med. 2003, 42:7-14.
45. Mathai J.P., Germain M., Shore G.C. BH3-only BIK regulates BAX, BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. J. Biol. Chem. 2005, 280:23829-23836.
46. Chen C.L., Lin C.F., Chang W.T., Huang W.C., Teng C.F., Lin Y.S. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 2008, 111:4365-4374.